Please login to the form below

Not currently logged in
Email:
Password:

Lilly appoints Philip Johnson to senior VP and treasurer

He currently serves as VP, investor relations at the pharma company

Eli Lilly and Company has appointed Philip Johnson to be its senior vice president, finance and treasure from January 1 2018.

He will report to Joshua Smiley, who will become senior vice president and chief financial officer from the same date.

He said: “Phil has been a trusted partner for our shareholders, effectively communicating the company’s results and expectations, while ensuring management’s actions are informed by shareholder input.

“With his external focus and experience in the capital markets, Phil is an ideal candidate to assume this important position and to help guide Lilly’s financial strategy.”

Johnson has been with Lilly for 22 years, serving in a variety of financial roles in the US and overseas.

He has served as vice president for investor relations since 2007, and before that he was vice president, finance and chief financial officer for global manufacturing and quality.

8th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics